Announcement

Collapse
No announcement yet.

NIH Study - Stem Cell - 3 year outcomes

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    NIH Study - Stem Cell - 3 year outcomes

    Three-year outcomes from an ongoing clinical trial suggest that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells may induce sustained remission in some people with relapsing-remitting multiple sclerosis (RRMS).

    http://www.nih.gov/news/health/dec2014/niaid-29.htm

    Three years after the treatment, called high-dose immunosuppressive therapy and autologous hematopoietic cell transplant or HDIT/HCT, nearly 80 percent of trial participants had survived without experiencing an increase in disability, a relapse of MS symptoms or new brain lesions. Investigators observed few serious early complications or unexpected side effects, although many participants experienced expected side effects of high-dose immunosuppression, including infections and gastrointestinal problems. The three-year findings are published in the Dec. 29, 2014, online issue of JAMA Neurology.


    http://archneur.jamanetwork.com/arti...icleid=2084840

    #2
    Thanks Marco. Encouraging news. Happy New Year !

    Comment


      #3
      I think that this is indeed encouraging news! Stem cell may be the answer for many many people, that not only have MS but other diseases as well.

      I have a friend that has a type of non Hodgkins Lymphoma that got stem cell treatment a few months ago. What a change in his life! Their hope was that it just stabilized his condition, but recent tests found that the cancer has "shrunk".

      Let's hope that they continue to do research on this and that more and more people have access to this treatment.

      Comment


        #4
        Yes, thank you, Marco. This is indeed encouraging news! Let's all hope these findings continue.

        Comment

        Working...
        X